eVusheld Assessment reaL wORld effectiveness at UPMC

Trial Identifier:	D8850R00001
Sponsor:	AstraZeneca
Collaborator:	UPMC
NCTID::	NCT05667116
Start Date:	January 2023
Primary Completion Date:	January 2024
Study Completion Date:	January 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
USA, Pennsylvania	Pittsburgh, Pennsylvania, USA, 15213

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.